SOPHiA GENETICS SA
SOPH- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- SEC CIK
- 0001840706
In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding SOPHiA GENETICS SA changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 49 | 71 | +22 |
| Shares | 24.3M | 36.8M | +12.5M (+51.5%) |
| Value | $120.4M | $212.5M | +$92.2M (+76.6%) |
New holders (26)
Institutions that held SOPHiA GENETICS SA at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (4)
Institutions that held SOPHiA GENETICS SA at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Susquehanna International Group, LLP | 13,156 | $65.1K |
| Advisor Group Holdings, Inc. | 1,000 | $4.95K |
| Federation des caisses Desjardins du Quebec | 700 | $3.46K |
| JPMorgan Chase & Co | 206 | $966 |